The #1 income play for 2023 is NOT a stock, bond or private company... Rather, it's a little-known alternative investment that could hand you big monthly income from oil and gas.

Find Out What It Is Right Here.

AVIR Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 12.80%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $214,741.56

Atea Pharmaceuticals Insider Trading History Chart

Atea Pharmaceuticals Share Price & Price History

^$4.50

▲ +0.42 (10.29%)

As of 06/2/2023 01:00 AM ET

Days: 30 | 90 | 365

The Ultimate Passive Income Play

From The Oxford Club | Ad

>>>

Atea Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/14/2022	Franklin M Berger	Director	Sell	16,166	$5.16	$83,416.56	778,353
11/11/2022	Franklin M Berger	Director	Sell	25,500	$5.15	$131,325.00	794,519
12/20/2021	Polly A. Murphy	Director	Buy	12,000	$8.57	$102,840.00

The Ultimate Passive Income Play

From The Oxford Club | Ad

>>>

SEC Filings (Institutional Ownership Changes) for Atea Pharmaceuticals (NASDAQ:AVIR)

68.92% of Atea Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Atea Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
6/1/2023	Prelude Capital Management LLC	28,500	$95K	0.0%	N/A	0.034%
5/22/2023	Ameriprise Financial Inc.	43,303	$0.15M	0.0%	+88.6%	0.052%
5/18/2023	JPMorgan Chase & Co.	62,213	$0.21M	0.0%	-70.4%	0.075%
5/18/2023	New York State Common Retirement Fund	16,377	$55K	0.0%	-64.6%	0.020%
5/16/2023	Susquehanna International Group LLP	185,457	$0.62M	0.0%	-67.9%	0.222%
5/16/2023	RBF Capital LLC	214,929	$0.72M	0.1%	-19.9%	0.258%
5/16/2023	Jane Street Group LLC	117,596	$0.39M	0.0%	-52.6%	0.141%
5/16/2023	State Street Corp	1,863,337	$6.24M	0.0%	-3.8%	2.234%
5/16/2023	Squarepoint Ops LLC	22,777	$76K	0.0%	-41.6%	0.027%
5/16/2023	First Trust Advisors LP	201,785	$0.68M	0.0%	+8.3%	0.242%
5/16/2023	Geode Capital Management LLC	1,490,064	$4.99M	0.0%	+3.7%	1.787%
5/16/2023	AQR Capital Management LLC	137,081	$0.46M	0.0%	-9.2%	0.164%
5/15/2023	Cubist Systematic Strategies LLC	75,562	$0.25M	0.0%	+83.7%	0.091%
5/15/2023	Deutsche Bank AG	57,206	$0.19M	0.0%	+81.7%	0.069%
5/15/2023	Ensign Peak Advisors Inc	68,480	$0.23M	0.0%	+39.8%	0.082%
5/15/2023	Price T Rowe Associates Inc. MD	39,744	$0.13M	0.0%	+37.9%	0.048%
5/15/2023	Stonepine Capital Management LLC	684,508	$2.29M	0.8%	N/A	0.821%
5/15/2023	XTX Topco Ltd	32,630	$0.11M	0.0%	N/A	0.039%
5/12/2023	Renaissance Technologies LLC	727,700	$2.44M	0.0%	+17.3%	0.873%
5/12/2023	Candriam S.C.A.	135,316	$0.42M	0.0%	-30.2%	0.162%
5/12/2023	BlackRock Inc.	8,041,736	$26.94M	0.0%	+0.1%	9.642%
5/12/2023	Sectoral Asset Management Inc.	380,850	$1.28M	0.2%	+35.3%	0.457%
5/12/2023	Bank of America Corp DE	136,523	$0.46M	0.0%	-21.7%	0.164%
5/12/2023	Prudential Financial Inc.	239,405	$0.80M	0.0%	-13.2%	0.287%
5/12/2023	HRT Financial LP	107,613	$0.36M	0.0%	-19.4%	0.129%
5/12/2023	UBS Group AG	52,813	$0.18M	0.0%	-29.8%	0.063%
5/12/2023	Martingale Asset Management L P	40,100	$0.13M	0.0%	-81.5%	0.048%
5/12/2023	Dimensional Fund Advisors LP	61,639	$0.21M	0.0%	N/A	0.074%
5/12/2023	Wellington Management Group LLP	286,233	$0.96M	0.0%	-3.9%	0.343%
5/12/2023	Charles Schwab Investment Management Inc.	526,349	$1.76M	0.0%	-6.8%	0.631%
5/11/2023	Acadian Asset Management LLC	1,110,715	$3.72M	0.0%	+27.9%	1.332%
5/11/2023	FMR LLC	11,573,379	$38.77M	0.0%	-1.4%	13.877%
5/11/2023	Rhumbline Advisers	123,687	$0.41M	0.0%	+4.7%	0.148%
5/10/2023	Swiss National Bank	161,800	$0.54M	0.0%	-10.6%	0.194%
5/9/2023	Bank of New York Mellon Corp	309,559	$1.04M	0.0%	-3.4%	0.371%
5/8/2023	New York Life Investment Management LLC	145,359	$0.49M	0.0%	+85.0%	0.174%
5/8/2023	CM Management LLC	325,000	$1.09M	1.3%	+18.2%	0.390%
5/8/2023	Federated Hermes Inc.	2,039,056	$6.83M	0.0%	-33.8%	2.445%
5/4/2023	Barclays PLC	38,759	$0.13M	0.0%	+48.6%	0.047%
5/3/2023	Integrated Wealth Concepts LLC	10,140	$34K	0.0%	N/A	0.012%
5/1/2023	Marquette Asset Management LLC	24,865	$83K	0.0%	N/A	0.030%
5/1/2023	CM Wealth Advisors LLC	19,400	$64K	0.0%	N/A	0.023%
4/28/2023	SG Americas Securities LLC	31,179	$0.10M	0.0%	-20.1%	0.037%
4/27/2023	Strs Ohio	95,200	$0.32M	0.0%	-25.6%	0.114%
4/21/2023	Congress Asset Management Co. MA	197,312	$0.66M	0.0%	+10.9%	0.237%
4/18/2023	ETF Managers Group LLC	26,460	$89K	0.0%	+27.4%	0.032%
4/13/2023	Allspring Global Investments Holdings LLC	23,716	$79K	0.0%	+619.8%	0.028%
4/12/2023	Vontobel Holding Ltd.	380,850	$1.28M	0.0%	+35.3%	0.457%
3/23/2023	ETF Managers Group LLC	20,765	$100K	0.0%	-15.5%	0.025%
2/28/2023	Voya Investment Management LLC	54,784	$0.26M	0.0%	+79.9%	0.066%
2/16/2023	Alliancebernstein L.P.	85,300	$0.41M	0.0%	+6.5%	0.102%
2/16/2023	State of Wyoming	31,906	$0.15M	0.1%	N/A	0.038%
2/15/2023	Public Employees Retirement System of Ohio	18,012	$87K	0.0%	-18.5%	0.022%
2/15/2023	State of Wisconsin Investment Board	215,252	$1.04M	0.0%	+18.9%	0.258%
2/15/2023	Squarepoint Ops LLC	39,014	$0.19M	0.0%	N/A	0.047%
2/15/2023	Millennium Management LLC	179,686	$0.86M	0.0%	N/A	0.216%
2/15/2023	Morgan Stanley	439,234	$2.11M	0.0%	-11.6%	0.527%
2/15/2023	Man Group plc	57,777	$0.28M	0.0%	-15.6%	0.069%
2/15/2023	Norges Bank	204,200	$0.98M	0.0%	N/A	0.245%
2/15/2023	Alps Advisors Inc.	56,612	$0.27M	0.0%	N/A	0.068%
2/15/2023	AQR Capital Management LLC	150,888	$0.73M	0.0%	+394.5%	0.181%
2/14/2023	PDT Partners LLC	65,985	$0.32M	0.1%	-4.0%	0.079%
2/14/2023	Alpine Global Management LLC	10,858	$52K	0.0%	N/A	0.013%
2/13/2023	Charles Schwab Investment Management Inc.	564,494	$2.72M	0.0%	+2.0%	0.678%
2/13/2023	Barclays PLC	26,082	$0.13M	0.0%	-29.6%	0.031%
2/13/2023	Renaissance Technologies LLC	620,600	$2.99M	0.0%	+3.9%	0.745%
2/13/2023	Credit Suisse AG	74,334	$0.36M	0.0%	+36.4%	0.089%
2/13/2023	Martingale Asset Management L P	216,285	$1.04M	0.0%	-6.1%	0.260%
2/13/2023	Geode Capital Management LLC	1,437,359	$6.91M	0.0%	+3.5%	1.726%
2/13/2023	GSA Capital Partners LLP	56,920	$0.27M	0.0%	N/A	0.068%
2/13/2023	JPMorgan Chase & Co.	210,018	$1.01M	0.0%	+13.5%	0.252%
2/10/2023	Bank of America Corp DE	174,346	$0.84M	0.0%	+35.7%	0.209%
2/10/2023	Tyrus Capital S.A.M.	1,260,000	$6.06M	13.2%	N/A	1.513%
2/10/2023	New York Life Investment Management LLC	78,563	$0.38M	0.0%	+12.7%	0.094%
2/10/2023	Sectoral Asset Management Inc.	281,403	$1.35M	0.3%	N/A	0.338%
2/10/2023	HRT Financial LP	133,597	$0.64M	0.0%	N/A	0.160%
2/10/2023	Blair William & Co. IL	10,458	$50K	0.0%	N/A	0.013%
2/9/2023	CM Management LLC	275,000	$1.32M	1.6%	+10.0%	0.330%
2/9/2023	First Trust Advisors LP	186,398	$0.90M	0.0%	-6.5%	0.224%
2/9/2023	Denali Advisors LLC	18,000	$87K	0.0%	+309.1%	0.022%
2/9/2023	Citigroup Inc.	8,188	$39K	0.0%	-57.8%	0.010%
2/8/2023	UBS Group AG	75,235	$0.36M	0.0%	+388.0%	0.090%
2/8/2023	Swiss National Bank	181,000	$0.87M	0.0%	+2.7%	0.217%
2/8/2023	Russell Investments Group Ltd.	17,008	$82K	0.0%	+277.3%	0.020%
2/7/2023	Envestnet Asset Management Inc.	20,173	$97K	0.0%	+14.1%	0.024%
2/2/2023	SG Americas Securities LLC	39,042	$0.19M	0.0%	-50.5%	0.047%
2/2/2023	Gladius Capital Management LP	7,913	$39K	0.0%	+63.2%	0.010%
1/26/2023	Strs Ohio	127,900	$0.62M	0.0%	+40.4%	0.154%
12/8/2022	Bank of New York Mellon Corp	306,856	$1.75M	0.0%	+13.6%	0.368%
11/21/2022	California State Teachers Retirement System	94,592	$0.54M	0.0%	-3.0%	0.114%
11/16/2022	Balyasny Asset Management LLC	751,073	$4.27M	0.0%	-58.3%	0.902%
11/15/2022	State Street Corp	1,894,736	$10.78M	0.0%	+5.1%	2.275%
11/15/2022	Jacobs Levy Equity Management Inc.	380,517	$2.17M	0.0%	-12.0%	0.457%
11/15/2022	Algert Global LLC	21,624	$0.12M	0.0%	-15.1%	0.026%
11/15/2022	Two Sigma Investments LP	98,482	$0.56M	0.0%	-10.9%	0.118%
11/15/2022	UBS Asset Management Americas Inc.	87,448	$0.50M	0.0%	-13.9%	0.105%
11/15/2022	Vanguard Group Inc.	7,584,256	$43.16M	0.0%	+5.6%	9.106%
11/15/2022	Price T Rowe Associates Inc. MD	27,621	$0.16M	0.0%	+19.7%	0.033%
11/15/2022	Martingale Asset Management L P	230,364	$1.31M	0.0%	+57.5%	0.277%
11/15/2022	EcoR1 Capital LLC	6,184,861	$35.19M	1.0%	-2.5%	7.426%

Data available starting January 2016

Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The company also develops AT-752, an oral purine nucleoside prodrug product candidate, which has completed Phase Ia clinical trial for the treatment of dengue; AT-777, an NS5A inhibitor; AT-787, a co-formulated, oral, pan-genotypic fixed dose combination of AT-527 and AT-777 for the treatment of hepatitis C virous (HCV); and AT-281, a pharmaceutically acceptable salt for the treatment or prevention of an RNA viral infection, including dengue fever, yellow fever, Zika virus, and coronaviridae viral infection, as well as Ruzasvir, an investigational oral, pan genotypic NS5A inhibitor for the treatment of chronic HCV infection. It has a license agreement with Merck & Co, Inc. for development and commercialization of ruzasvir for the treatment of HCV. Atea Pharmaceuticals, Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.

Today's Range

Now: $4.50

$4.10

$4.52

50 Day Range

MA: $3.59

$3.12

$5.06

52 Week Range

Now: $4.50

$2.94

$9.79

Volume

1,290,963 shs

Average Volume

1,206,703 shs

Market Capitalization

$375.30 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.23

Who are the company insiders with the largest holdings of Atea Pharmaceuticals?: Atea Pharmaceuticals' top insider investors include:
Franklin M Berger (Director)
Polly A Murphy (Director)
Learn More about top insider investors at Atea Pharmaceuticals.
Who are the major institutional investors of Atea Pharmaceuticals?: Atea Pharmaceuticals' top institutional investors include:
FMR LLC — 13.88%
BlackRock Inc. — 9.64%
Federated Hermes Inc. — 2.44%
State Street Corp — 2.23%
Geode Capital Management LLC — 1.79%
Acadian Asset Management LLC — 1.33%
Learn More about top institutional investors of Atea Pharmaceuticals stock.
Which institutional investors are selling Atea Pharmaceuticals stock?: In the last quarter, AVIR stock was sold by these institutional investors:
Federated Hermes Inc.
Susquehanna International Group LLP
Martingale Asset Management L P
FMR LLC
JPMorgan Chase & Co.
Jane Street Group LLC
State Street Corp
Candriam S.C.A.
Which institutional investors are buying Atea Pharmaceuticals stock?: Within the previous quarter, AVIR stock was bought by institutional investors including:
Stonepine Capital Management LLC
Acadian Asset Management LLC
Renaissance Technologies LLC
Sectoral Asset Management Inc.
Vontobel Holding Ltd.
New York Life Investment Management LLC
Dimensional Fund Advisors LP
Geode Capital Management LLC

The Ultimate Passive Income Play

From The Oxford Club | Ad

>>>

AVIR Insider Trading

Atea Pharmaceuticals Insider Trading History Chart

Atea Pharmaceuticals Share Price & Price History

Atea Pharmaceuticals Insider Trading History

SEC Filings (Institutional Ownership Changes) for Atea Pharmaceuticals (NASDAQ:AVIR)

Institutional Buying and Selling by Quarter

Atea Pharmaceuticals Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of Atea Pharmaceuticals?

Who are the major institutional investors of Atea Pharmaceuticals?

Which institutional investors are selling Atea Pharmaceuticals stock?

Which institutional investors are buying Atea Pharmaceuticals stock?